These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2198957

  • 1. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection.
    Pluda JM, Yarchoan R, Smith PD, McAtee N, Shay LE, Oette D, Maha M, Wahl SM, Myers CE, Broder S.
    Blood; 1990 Aug 01; 76(3):463-72. PubMed ID: 2198957
    [Abstract] [Full Text] [Related]

  • 2. A phase I study of therapy with recombinant granulocyte-macrophage colony-stimulating factor administered by IV bolus or continuous infusion.
    Rifkin RM, Hersh EM, Salmon SE.
    Behring Inst Mitt; 1988 Aug 01; (83):125-33. PubMed ID: 3071327
    [Abstract] [Full Text] [Related]

  • 3. Recombinant human granulocyte-macrophage colony-stimulating factor ameliorates zidovudine-induced neutropenia in patients with acquired immunodeficiency syndrome (AIDS)/AIDS-related complex.
    Levine JD, Allan JD, Tessitore JH, Falcone N, Galasso F, Israel RJ, Groopman JE.
    Blood; 1991 Dec 15; 78(12):3148-54. PubMed ID: 1742482
    [Abstract] [Full Text] [Related]

  • 4. The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells.
    Bhalla K, Birkhofer M, Grant S, Graham G.
    Exp Hematol; 1989 Jan 15; 17(1):17-20. PubMed ID: 2783247
    [Abstract] [Full Text] [Related]

  • 5. Potential role of granulocyte-macrophage colony stimulating factor in patients with HIV infection.
    Mitsuyasu RT, Golde DW.
    Behring Inst Mitt; 1988 Aug 15; (83):139-44. PubMed ID: 3071329
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine.
    Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA.
    Blood; 1991 May 15; 77(10):2109-17. PubMed ID: 1709368
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages.
    Hammer SM, Gillis JM, Pinkston P, Rose RM.
    Blood; 1990 Mar 15; 75(6):1215-9. PubMed ID: 2178702
    [Abstract] [Full Text] [Related]

  • 12. Effect of recombinant granulocyte-macrophage colony-stimulating factor on murine thrombocytopoiesis in vitro and in vivo.
    Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Maruyama Y.
    Blood; 1990 Apr 01; 75(7):1433-8. PubMed ID: 2180495
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A phase I/II trial of recombinant granulocyte-macrophage colony-stimulating factor for children with aplastic anemia.
    Guinan EC, Sieff CA, Oette DH, Nathan DG.
    Blood; 1990 Sep 15; 76(6):1077-82. PubMed ID: 2205306
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression.
    Antman KS, Griffin JD, Elias A, Socinski MA, Ryan L, Cannistra SA, Oette D, Whitley M, Frei E, Schnipper LE.
    N Engl J Med; 1988 Sep 08; 319(10):593-8. PubMed ID: 3045544
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor.
    Vadhan-Raj S, Buescher S, LeMaistre A, Keating M, Walters R, Ventura C, Hittelman W, Broxmeyer HE, Gutterman JU.
    Blood; 1988 Jul 08; 72(1):134-41. PubMed ID: 3291976
    [Abstract] [Full Text] [Related]

  • 19. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR, del Castillo J, McNiece I, Watson L, Yin SM, Andresen J.
    Am J Pathol; 1990 Aug 08; 137(2):369-76. PubMed ID: 1696784
    [Abstract] [Full Text] [Related]

  • 20. Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
    Lieschke GJ, Maher D, Cebon J, O'Connor M, Green M, Sheridan W, Boyd A, Rallings M, Bonnem E, Metcalf D.
    Ann Intern Med; 1989 Mar 01; 110(5):357-64. PubMed ID: 2644886
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.